1-17 of 17
Rajesh Kamalakar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Response Rates across Lines of Therapy Among Patients with Relapsed/Refractory Follicular Lymphoma

Tycel Philips, Laurie H. Sehn, Anthony Wang, Junhua Yu, Elizabeth H. Marchlewicz, Rajesh Kamalakar, Kavita Sail, Donald Arnette, Shibing Yang, Alex Mutebi, Fernando Rivas Navarro, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 1683.
https://doi.org/10.1182/blood-2023-180088
Published: 2023
Journal Articles

Real-World Progression-Free Survival and Treatment Patterns for t(11;14) Positive Patients with Multiple Myeloma with at Least 2 Prior Lines of Treatment

Allicia Girvan, Daniel Martins, Junhua Yu, Sophia Ng, Rajesh Kamalakar, Faiza Zafar, Seema Tulsian, Robert F. Cornell, Mohamed Samir
Journal: Blood
Blood (2023) 142 (Supplement 1): 6667.
https://doi.org/10.1182/blood-2023-173446
Published: 2023
Journal Articles

Psychometric Validation and Meaningful Change Threshold Determination of EORTC QLQ-C30 Physical Functioning and Promis SF v1.0-Fatigue 7a Functional Domain in Patients with High-Risk Myelodysplastic Syndromes Treated with Venetoclax and Azacitidine

Roger M. Lyons, Brandon Foster, Adrian Jewett, Liu Liu, Rohini Sen, Cat N. Bui, Rajesh Kamalakar, Jalaja Potluri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6472.
https://doi.org/10.1182/blood-2023-178011
Published: 2023
Journal Articles

Effectiveness of Chemo-Immunotherapy (CIT) and Novel Therapies in Second or Later Line of Therapy (2L+) for Patients with Relapsed/Refractory (R/R) Aggressive Large B-Cell Lymphoma (LBCL)

Loretta J. Nastoupil, Clark R. Andersen, Amy Ayers, Yucai Wang, Thomas M. Habermann, Dai Chihara, Brad S. Kahl, Brian K. Link, Jonathon B. Cohen, Peter Martin, Izidore S. Lossos, Carla Casulo, Ruitao Lin, Ziyi Li, Melissa C. Larson, Matthew J. Maurer, Lynn Huynh, Chi Gao, Ramya Ramasubramanian, Mei Sheng Duh, Alex Mutebi, Tongsheng Wang, Monika Jun, Anthony Wang, Rajesh Kamalakar, Anupama Kalsekar, James R. Cerhan, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 309.
https://doi.org/10.1182/blood-2023-174497
Published: 2023
Journal Articles

Follicular Lymphoma Treatment Patterns and Outcomes over Time: A Real-World Analysis in the United States

Tycel Phillips, Junhua Yu, Rajesh Kamalakar, Kalatu R. Davies, Alex Mutebi, Savreet Bains Chawla, Donald Arnette, Syed Quadri, Anthony Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 5241–5243.
https://doi.org/10.1182/blood-2022-157773
Published: 2022
Journal Articles

Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis

Andrew Ip, Alex Mutebi, Tongsheng Wang, Monika P. Jun, Anupama Kalsekar, Fernando Rivas Navarro, Anthony Wang, Rajesh Kamalakar, Mariana Sacchi, Brian Elliott
Journal: Blood
Blood (2022) 140 (Supplement 1): 6693–6694.
https://doi.org/10.1182/blood-2022-159569
Published: 2022
Journal Articles

Real-World Treatment Patterns and Transfusion Burden Among Newly Diagnosed Older Adults with Acute Myeloid Leukemia

Amer M. Zeidan, Wei-Han Cheng, Rajesh Kamalakar, Catherine Miller, Cat N. Bui, Melissa Montez, Tracy Yee, Zheng Wu, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 3282–3283.
https://doi.org/10.1182/blood-2022-160002
Published: 2022
Journal Articles

Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Receiving ≥3 Lines of Therapy: A Real-World Evaluation in the United States

Allicia Girvan, Junhua Yu, Rajesh Kamalakar, Elizabeth S. Mearns, Michael Nixon, Robert F. Cornell
Journal: Blood
Blood (2022) 140 (Supplement 1): 5288–5290.
https://doi.org/10.1182/blood-2022-156225
Published: 2022
Journal Articles

Real-World Treatment Patterns and Outcomes of Daratumumab Retreatment in Multiple Myeloma in the United States

Allicia Girvan, Junhua Yu, Nnadozie Emechebe, Rajesh Kamalakar, Yan Luo
Journal: Blood
Blood (2022) 140 (Supplement 1): 5266–5267.
https://doi.org/10.1182/blood-2022-158270
Published: 2022
Journal Articles

Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis

Kalatu R. Davies, Rajesh Kamalakar, Junhua Yu, Yinan Huang, Anthony Wang, Kavita Sail, Thomas Doerr, Simon Sharmokh, Alex Mutebi, Gilles Salles
Journal: Blood
Blood (2022) 140 (Supplement 1): 5058–5059.
https://doi.org/10.1182/blood-2022-157758
Published: 2022
Journal Articles

Venetoclax Effectiveness, Safety, and Treatment Patterns in Chronic Lymphocytic Leukemia Patients: Results from the CLL Collaborative Study of Real-World Evidence (CORE)

Dandan Zheng, Kavita Sail, PhD, Lindsey E Roeker, MD, Beenish S Manzoor, PhD, Hande H. Tuncer, MD, John N. Allan, MD, Chaitra S. Ujjani, MD, Paul M. Barr, MD, Jennifer R. Brown, MD PhD, Toby A. Eyre, Alan Skarbnik, MD, Rajat Bannerji, MDPhD, Barbara Eichhorst, MD, Danielle M. Brander, MD, Simon Sharmokh, MPH, PharmD, Daniel Dingfeng Jiang, MD PhD, German Pena, MD, Rajesh Kamalakar, MS, Nnadozie Emechebe, MPH, Irina Pivneva, Rebecca Burne, Annie Guerin, MSc, Matthew S. Davids, MD, Anthony Mato, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–22.
https://doi.org/10.1182/blood-2020-134676
Published: 2020
Journal Articles

Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study

Jacqueline S. Garcia, MD, Andrew H. Wei, Uma Borate, Chun Yew Fong, MBBS, PhD FRACP, FRCPA, Maria R. Baer, MD, Florian Nolte, MD, Joseph G. Jurcic, MD, Meagan A. Jacoby, MD, Wan-Jen Hong, MD, Uwe Platzbecker, Olatoyosi Odenike, MD, Ilona Cunningham, MBBS, FRACP, FRCPA, Ying Zhou, PhD, Bo Tong, PhD, Leah Hogdal, PhD, Rajesh Kamalakar, MS, Jessica E. Hutti, PhD, Steve Kye, MD MPH, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 55–57.
https://doi.org/10.1182/blood-2020-139492
Published: 2020
Journal Articles

Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine

Keith W. Pratz, MD, Panayiotis Panayiotidis, MD, Christian Recher, MD PhD, Xudong Wei, PhD, Brian A Jonas, MD PhD, Pau Montesinos, MD PhD, Vladimir Ivanov, Andre C. Schuh, Courtney D. Dinardo, MDMSc, Jan Novak, Vlatko Pejsa, MD PhD, Don A. Stevens, MD, Su-Peng Yeh, MD, Inho Kim, MD PhD, Mehmet Turgut, MD, Nicola Fracchiolla, Kazuhito Yamamoto, MD PhD, Yishai Ofran, MD, Andrew H Wei, MBBS, PhD, Cat Bui, Katy Benjamin, Rajesh Kamalakar, MS, Jalaja Potluri, MD, Wellington Mendes, Jacob Devine, Walter Fiedler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–35.
https://doi.org/10.1182/blood-2020-133912
Published: 2020
Journal Articles

Economic Burden of Multiple Myeloma: Results from a Large Employer-Sponsored Real-World Administrative Claims Database, 2012 to 2018

Dao Tran, Rajesh Kamalakar, MS, Shivaji Manthena, Sudeep Karve, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3414.
https://doi.org/10.1182/blood-2019-131264
Published: 2019
Journal Articles

Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study

Mazyar Shadman, MD MPH, Kavita Sail, PhD, Beenish S Manzoor, PhD, Maryam Sarraf Yazdy, MD, Brian T. Hill, MD, Hande H. Tuncer, MD, John N. Allan, MD, Chaitra S. Ujjani, MD, Nnadozie Emechebe, MPH, Rajesh Kamalakar, MS, Simon Sharmokh, MPH, PharmD, Daniel Dingfeng Jiang, MD PhD, German Pena, MD, Thomas Marshall, PharmD, MS, Jacqueline Nielsen, PhD, Paul M. Barr, MD, Jennifer R. Brown, MD PhD, Anna Schuh, PhD, Toby A. Eyre, MD, Nicole Lamanna, MD, William G. Wierda, MD PhD, Alan Skarbnik, MD, Lindsey E. Roeker, MD, Rajat Bannerji, MD PhD, James M. Pauff, MD PhD, Stephen J. Schuster, MD, George A Follows, MD PhD, Bruce D. Cheson, MD, Barbara F. Eichhorst, MD, Danielle M. Brander, MD, Irina Pivneva, PhD, Annie Guerin, MSc, Anthony R. Mato, MDMSCE
Journal: Blood
Blood (2019) 134 (Supplement_1): 3048.
https://doi.org/10.1182/blood-2019-131401
Published: 2019
Journal Articles

Transfusion Requirements and Hospitalization during First Line Treatment Among Newly Diagnosed Acute Myeloid Leukemia Patients Who Were Ineligible for Intensive Chemotherapy

Cat N. Bui, PhD, Thomas Marshall, PharmD, MS, Rajesh Kamalakar, MS, Tracey Posadas, PharmD, MPH, Jalaja Potluri, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4849.
https://doi.org/10.1182/blood-2018-99-117247
Published: 2018
Journal Articles

Treatment Outcomes Among Chronic Lymphocytic Leukemia Patients with 17p Deletion or TP53 Mutation in Argentina: A Retrospective Chart Review

Miguel A. Pavlovsky, MD, Kavita Sail, PhD, Leonardo Passos Chaves, MD MSc, Rajesh Kamalakar, MS, Xiaojing Ma, MS, Patricia Brandalise, MD MSC, Carlos Chiattone, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5617.
https://doi.org/10.1182/blood.V130.Suppl_1.5617.5617
Published: 2017